UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040730
Receipt number R000046501
Scientific Title Oral immunotherapy with low allergenic egg contains cookies in 0-5 year old patients
Date of disclosure of the study information 2020/06/12
Last modified on 2020/06/12 12:06:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Oral immunotherapy with low allergenic egg contains cookies in 0-5 year old patients

Acronym

Oral immunotherapy with low allergenic egg contains cookies

Scientific Title

Oral immunotherapy with low allergenic egg contains cookies in 0-5 year old patients

Scientific Title:Acronym

Oral immunotherapy with low allergenic egg contains cookies

Region

Japan


Condition

Condition

egg allergy

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of oral immunotherapy from infants.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The comparison of the final dose in the oral boiled egg white challenge test after immunotherapy.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

egg white containing cookies

Interventions/Control_2

egg yolk containing cookies

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

7 months-old <=

Age-upper limit

73 months-old >

Gender

Male and Female

Key inclusion criteria

egg allergy

Key exclusion criteria

Allergic to ingredients other than egg
non-IgE mediated allergy
Plan to move within 4 months

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yuri
Middle name
Last name Takaoka

Organization

osaka Habikino medical center

Division name

department of pediatrics

Zip code

5838588

Address

3-7-1, Habikino, Habikino city

TEL

0729572121

Email

zvb11075@nifty.com


Public contact

Name of contact person

1st name Yuri
Middle name
Last name Takaoka

Organization

osaka habikino medical center

Division name

department of pediatrics

Zip code

5838588

Address

3-7-1, Habikino, Habikino city

TEL

0729572121

Homepage URL


Email

zvb11075@nifty.com


Sponsor or person

Institute

osaka habikino medical center

Institute

Department

Personal name



Funding Source

Organization

osaka habikino medical center

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

osaka Habikino medical center

Address

3-7-1, Habikino, Habikino city

Tel

0729572121

Email

zvb11075@nifty.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 06 Month 01 Day

Date of IRB

2018 Year 07 Month 13 Day

Anticipated trial start date

2018 Year 10 Month 01 Day

Last follow-up date

2023 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 12 Day

Last modified on

2020 Year 06 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046501


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name